Research Article

Surgical Approach in Liver Hemangiomas with Special Emphasis on Lesion Diameter and Type of Surgery: A Retrospective Cohort of 69 Patients

Volume: 14 Number: 2 March 17, 2023
EN

Surgical Approach in Liver Hemangiomas with Special Emphasis on Lesion Diameter and Type of Surgery: A Retrospective Cohort of 69 Patients

Abstract

Purpose: Liver hemangioma (LH) being the most common benign tumor of the liver is a rare indication for liver surgery. Indications include symptomatic disease, diagnostic suspicion of malignancy, increase in lesion size, and Kasabach-Merritt syndrome. Surgical treatment mainly consists of enucleation or liver resection (LR). The study aimed to evaluate surgical outcomes in patients with LHs. Methods: In this study, surgical treatment for liver hemangioma in a single center were retrospectively reviewed. Demographics, preoperative and postoperative laboratory values, imaging studies, and follow-up data of patients were collected. Results: The mean age was 51.9±11.0 years and 69.6% were female. Abdominal pain was present preoperatively in 32 (46.4%) cases. Mean lesion diameter was 7.5 (1.2-20) cm. Giant hemangioma was reported in 54 (78.3%) patients. Liver resection (LR) and enucleation were preferred for 37 (53.6%) and 32 (46.4%) patients, respectively. Intraoperative transfusion requirement was more common in enucleation than LRs (78.1% vs. 48.6%, p=0.012). Intraoperative erythrocyte transfusion was more frequently in operations of giant hemangiomas (68.5% vs. 40.0%, p=0.044). Complications were observed more frequently in giant hemangioma group regardless of grades (40.7% vs. 13.3%, p=0.049). Preoperative thrombocytopenia was found more frequent in cases with serious complications (66.7% vs 22.2%, p=0.019). Conclusion: Emerging percutaneous intervention and imaging modalities are expected to decrease number of surgeries for liver hemangiomas. Although enucleation, LR and even liver transplantation are still required for a set of patients. Enucleation and LR have similar outcomes, but transfusions are more common according to the present study. Size of LHs is related with complications and transfusion requirements.

Keywords

References

  1. 1. Ishak KG, Rabin L. Benign tumors of the liver. Med Clin North Am. 1975; 59 (4): 995–1013.
  2. 2. Hamaloglu E, Altun H, Ozdemir A, et al. Giant liver hemangioma: Therapy by enucleation or liver resection. World J Surg. 2005; 29 (7): 890–3.
  3. 3. Clavien PA, Barkun J, de Oliveira ML, et al. The Clavien-Dindo classification of surgical complications. Ann Surg. 2009; 250 (2): 187–96.
  4. 4. Agha R, Abdall-Razak A, Crossley E, et al. STROCSS 2019 Guideline: Strengthening the reporting of cohort studies in surgery. Int J Surg. 2019; 72: 156–65.
  5. 5. Alper A. Treatment of liver hemangiomas by enucleation. Arch Surg. 1988; 123 (5):660.
  6. 6. Nichols FC, van Heerden JA, Weiland LH. Benign liver tumors. Surg Clin North Am. 1989; 69 (2): 297–314.
  7. 7. Liu Y, Wei X, Wang K, et al. Enucleation versus anatomic resection for giant hepatic hemangioma: A meta-analysis. Gastrointest Tumors. 2016; 3 (3–4): 153–62.
  8. 8. Cheng W, Qi Y, Wang B, et al. Enucleation versus hepatectomy for giant hepatic haemangiomas: a meta-analysis. Ann R Coll Surg Engl. 2017; 99 (3): 237–41.

Details

Primary Language

English

Subjects

Surgery

Journal Section

Research Article

Publication Date

March 17, 2023

Submission Date

August 17, 2022

Acceptance Date

January 10, 2023

Published in Issue

Year 2023 Volume: 14 Number: 2

EndNote
Kırımker EO, Çelik SU, Kütük D, Ersöz Ş, Konca C, Koç MA, Tüzüner A, Karayalçın MK, Balcı D (March 1, 2023) Surgical Approach in Liver Hemangiomas with Special Emphasis on Lesion Diameter and Type of Surgery: A Retrospective Cohort of 69 Patients. Acıbadem Üniversitesi Sağlık Bilimleri Dergisi 14 2 119–124.